Evidence based medicine has confirmed the advantage of ACEI and CCB therapy in controlling blood pressure,lowering the incidence and the mortality of coronary disease.

• 循证医学证实了选择血管紧张素转换酶抑制剂+钙离子拮抗剂优化联合降压治疗方案对降压达标以及降低冠心病的发生率、病死率具有更明显的优势。